Given the previously reported predictive value of hENT1 tumour expression for adjuvant gemcitabine, we also explored the potentially additional value of DPD tumour expression in those high or low hENT1 intra-tumoural expression subgroups. This evidence concerns the gene SLC29A1 and neoplasm.